These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

463 related items for PubMed ID: 21167777

  • 1. The late complications of totally implantable central venous access ports: the results from an Italian multicenter prospective observation study.
    Dal Molin A, Rasero L, Guerretta L, Perfetti E, Clerico M.
    Eur J Oncol Nurs; 2011 Dec; 15(5):377-81. PubMed ID: 21167777
    [Abstract] [Full Text] [Related]

  • 2. Totally implantable venous access port systems and risk factors for complications: a one-year prospective study in a cancer centre.
    Narducci F, Jean-Laurent M, Boulanger L, El Bédoui S, Mallet Y, Houpeau JL, Hamdani A, Penel N, Fournier C.
    Eur J Surg Oncol; 2011 Oct; 37(10):913-8. PubMed ID: 21831566
    [Abstract] [Full Text] [Related]

  • 3. Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device.
    Biffi R, Corrado F, de Braud F, de Lucia F, Scarpa D, Testori A, Orsi F, Bellomi M, Mauri S, Aapro M, Andreoni B.
    Eur J Cancer; 1997 Jul; 33(8):1190-4. PubMed ID: 9301441
    [Abstract] [Full Text] [Related]

  • 4. Totally implantable venous access ports: retrospective review of long-term complications in 81 patients.
    Bassi KK, Giri AK, Pattanayak M, Abraham SW, Pandey KK.
    Indian J Cancer; 2012 Jul; 49(1):114-8. PubMed ID: 22842178
    [Abstract] [Full Text] [Related]

  • 5. Risk of thrombosis and infections of central venous catheters and totally implanted access ports in patients treated for cancer.
    Beckers MM, Ruven HJ, Seldenrijk CA, Prins MH, Biesma DH.
    Thromb Res; 2010 Apr; 125(4):318-21. PubMed ID: 19640573
    [Abstract] [Full Text] [Related]

  • 6. [Subcutaneous chamber systems (ports) for long-term care in cancer patients].
    Hájek R, Sevcík P, Ondrásek J, Mayer J, Vásová I, Král Z, Tomíska M, Krahulcová E, Penka M, Kubesová H.
    Vnitr Lek; 1995 Jan; 41(1):21-7. PubMed ID: 7716888
    [Abstract] [Full Text] [Related]

  • 7. Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days.
    Biffi R, de Braud F, Orsi F, Pozzi S, Mauri S, Goldhirsch A, Nolè F, Andreoni B.
    Ann Oncol; 1998 Jul; 9(7):767-73. PubMed ID: 9739444
    [Abstract] [Full Text] [Related]

  • 8. Comparison of totally implanted reservoirs with external catheters as venous access devices in pediatric oncologic patients.
    Ross MN, Haase GM, Poole MA, Burrington JD, Odom LF.
    Surg Gynecol Obstet; 1988 Aug; 167(2):141-4. PubMed ID: 3400032
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Higher complication risk of totally implantable venous access port systems in patients with advanced cancer - a single institution retrospective analysis.
    Chang YF, Lo AC, Tsai CH, Lee PY, Sun S, Chang TH, Chen CC, Chang YS, Chen JR.
    Palliat Med; 2013 Feb; 27(2):185-91. PubMed ID: 22126844
    [Abstract] [Full Text] [Related]

  • 11. [Implantable catheter systems. Experiences with 1000 patients with central venous ports].
    Kock HJ, Krause U, Pietsch M, Rasfeld S, Walz MK.
    Dtsch Med Wochenschr; 1996 Jan 19; 121(3):47-51. PubMed ID: 8565809
    [Abstract] [Full Text] [Related]

  • 12. Totally implantable central venous access ports in patients with cystic fibrosis: a multicenter prospective cohort study.
    Dal Molin A, Di Massimo DS, Braggion C, Bisogni S, Rizzi E, D'Orazio C, Di Toppa MV, Alghisi F, Cristadoro S, Carnovale V, Festa G, Rampini S, Colombo C, Oneta A, Furnari ML, Calamia MA, Zunino ML, Tuccio G, Spadea V, Messore B, Grosso B, Festini F.
    J Vasc Access; 2012 Jan 19; 13(3):290-5. PubMed ID: 22266592
    [Abstract] [Full Text] [Related]

  • 13. Retrospective evaluation of totally implantable venous access port devices: early and late complications.
    Gurkan S, Seber S, Gur O, Yetisyigit T, Okan Donbaloglu M, Ozkaramanli Gur D.
    J BUON; 2015 Jan 19; 20(1):338-45. PubMed ID: 25778336
    [Abstract] [Full Text] [Related]

  • 14. Long-term experience with a totally implanted catheter system in gynecologic oncologic patients.
    Koonings PP, Given FT.
    J Am Coll Surg; 1994 Feb 19; 178(2):164-6. PubMed ID: 8173727
    [Abstract] [Full Text] [Related]

  • 15. A peripherally implanted permanent central venous access device.
    Morris P, Buller R, Kendall S, Anderson B.
    Obstet Gynecol; 1991 Dec 19; 78(6):1138-42. PubMed ID: 1945224
    [Abstract] [Full Text] [Related]

  • 16. Incidence of mechanical malfunction in low-profile subcutaneous implantable venous access devices in patients receiving chemotherapy for gynecologic malignancies.
    Subramaniam A, Kim KH, Bryant SA, Kimball KJ, Huh WK, Straughn JM, Estes JM, Alvarez RD.
    Gynecol Oncol; 2011 Oct 19; 123(1):54-7. PubMed ID: 21742372
    [Abstract] [Full Text] [Related]

  • 17. Infectious port complications are more frequent in younger patients with hematologic malignancies than in solid tumor patients.
    Samaras P, Dold S, Braun J, Kestenholz P, Breitenstein S, Imhof A, Renner C, Stenner-Liewen F, Pestalozzi BC.
    Oncology; 2008 Oct 19; 74(3-4):237-44. PubMed ID: 18716418
    [Abstract] [Full Text] [Related]

  • 18. [Central venous totally implantable access for high dose chemotherapy in children].
    Conter C, Carausu L, Martin E, Rubie H, Castex MP, Marec-Berard P.
    Arch Pediatr; 2006 Mar 19; 13(3):256-61. PubMed ID: 16469486
    [Abstract] [Full Text] [Related]

  • 19. Radiologic placement of a low profile implantable venous access port in a pediatric population.
    Nosher JL, Bodner LJ, Ettinger LJ, Siegel RL, Gribbin C, Asch J, Drachtman RA.
    Cardiovasc Intervent Radiol; 2001 Mar 19; 24(6):395-9. PubMed ID: 11907746
    [Abstract] [Full Text] [Related]

  • 20. [Totally implantable venous access ports: frequency of complications and analysis of bacterial contamination after ablation].
    Barbut F, Soukouna S, Lalande V, Garcia ML, Neyme D, de Gramont A, Petit JC.
    Pathol Biol (Paris); 2004 Dec 19; 52(10):566-74. PubMed ID: 15596304
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.